Children: Clinical Trials

21 trials for Children, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 4 unknown, 2 recruiting, 1 active not recruiting. 21 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 13, Unknown 4, Recruiting 2, Active not recruiting 1, Terminated 1
Phase 23Recruiting 1, Terminated 1, Unknown 1

Follow Children: new trials by email Literature Review of Children trials Research Report on Children

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Versus Intravenous Magnesium on Emergence Delirium
Magnesium glycinate, Magnesium sulfate injection, Oral juice and intravenous saline - Magnesium, Emergence Delirium
Phase 2 / Phase 3RecruitingTanta University3602026-07-012026-07-06
Microbiote's Evolution After Use of Nitrous Oxide on Pediatric Patient Needing Airway Samples
MEOPA, Standard induced sputum - Respiratory Ilness, Children
Phase 3CompletedUniversity Hospital, Brest232025-09-242026-06-15
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
MVA-BN standard regimen, MVA-BN half-dose regimen - Mpox (Monkeypox), Vaccination
Phase 3Active not recruitingJean-Pierre Van geertruyden3442025-05-292026-04-29
A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)
Gadoquatrane (BAY1747846) - Contrast Enhancement in Magnetic Resonance Imaging, Children
Phase 3CompletedBayer1052023-08-162026-07-17
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Finerenone (Kerendia, BAY94-8862) - Chronic Kidney Disease, Proteinuria
Phase 3RecruitingBayer1002022-11-082026-09-24
Study of Atropine Therapeutic Effect on Myopic Progression
Atropine Sulfate 01, Atropine Sulfate 02, Atropine Sulfate 03 - Myopia, Children
Phase 3UnknownLitePharmTech Co., Ltd.4722022-05-252023-02-23
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
Damoctocog alfa pegol (Jivi, BAY94-9027) - Treatment of Bleeding, Prophylaxis of Bleeding
Phase 3CompletedBayer362022-03-232026-07-02
Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children
Acetaminophen, Analgesics, Non-Narcotic, Hyoscine butylbromide, Analgesics, Non-Narcotic - Abdomen, Acute, Children
Phase 3CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2362017-03-202019-05-02
Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
Zinc group, Placebo group - Diarrhea, Children
Phase 3UnknownHospital General Naval de Alta Especialidad - Escuela Medico Naval3502015-11-012015-11-10
Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.
0.9% saline solution, oral betamethasone placebo, adrenaline - Children, Bronchiolitis
Phase 2 / Phase 3TerminatedAssistance Publique - Hôpitaux de Paris1952015-10-012017-09-12
Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia
Remifentanil and/or propofol, propofol - Children, Heart Diseases
Phase 3UnknownAlder Hey Children's NHS Foundation Trust352015-07-012019-01-10
Asthma Action at Erie Trial
Community Health Worker, Certified asthma educator - Asthma, Children
Phase 3CompletedUniversity of Illinois at Chicago2232015-04-012021-12-09
The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children
Melatonin, Chloral Hydrate - Epilepsy, Electroencephalogram
Phase 3CompletedUniversity of Cape Town1942014-04-012017-11-30
PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin
Melatonin, Sugar pill - Post-concussion Syndrome, Post-concussive Symptoms
Phase 2 / Phase 3UnknownUniversity of Calgary992013-09-012017-04-18
Compliance With Dietary Recommendations in Children at Risk for Undernutrition
nutritional supplement - Children, Under-nutrition
Phase 3CompletedAbbott Nutrition2002011-10-012015-01-21
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
Botulinum toxin type A - Cerebral Palsy, Muscle Spasticity
Phase 3CompletedIpsen2162011-10-012022-09-28
Dysport® Pediatric Lower Limb Spasticity Study
Botulinum toxin type A, Placebo - Cerebral Palsy, Muscle Spasticity
Phase 3CompletedIpsen2412011-07-012022-09-28
Intravenous Immunoglobulin for PANDAS
Gamunex Intravenous Immunoglobulin, Placebo - Obsessive-Compulsive Disorder, Children
Phase 3CompletedNational Institute of Mental Health (NIMH)482011-01-012020-03-17
Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence
Mictonetten 5 mg, coated tablet, placebo - Overactive Bladder, Urinary Incontinence
Phase 3CompletedAPOGEPHA Arzneimittel GmbH3032004-06-012008-01-29
ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia
Oral Co-trimoxazole (8mg/kg/day trimithoprim) twice a day for five days vs. oral amoxycillin (20 mg/kg/day) thrice a day for three days. - Non-Severe Pneumonia, Under-Fives
Phase 3CompletedKing George's Medical University20002004-04-012006-12-07

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Cerebral Palsy (2)  ·  Muscle Spasticity (2)  ·  Abdomen, Acute (1)  ·  Anxiety Disorders (1)  ·  Asthma (1)  ·  Autoimmune Diseases (1)  ·  Brain Concussion (1)  ·  Brain Injuries, Traumatic (1)  ·  Bronchiolitis (1)  ·  Cardiovascular Diseases (1)  ·  Diarrhea (1)  ·  Disease Progression (1)  ·  Emergence Delirium (1)  ·  Epilepsy (1)  ·  Heart Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (7)  ·  Nervous System Diseases (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Brain Damage, Chronic (2)  ·  Bronchial Diseases (2)  ·  Chronic Disease (2)

Interventions

Botulinum Toxins, Type A (2)  ·  Melatonin (2)  ·  abobotulinumtoxinA (2)  ·  Acetaminophen (1)  ·  Analgesics (1)  ·  Betamethasone (1)  ·  Butylscopolammonium Bromide (1)  ·  Chloral Hydrate (1)  ·  Community Health Workers (1)  ·  Dietary Supplements (1)  ·  Epinephrine (1)  ·  Factor VIII (1)  ·  Magnesium Sulfate (1)  ·  Meopa (1)  ·  Propofol (1)

Sponsors

Bayer (3)  ·  Ipsen (2)  ·  APOGEPHA Arzneimittel GmbH (1)  ·  Abbott Nutrition (1)  ·  Alder Hey Children's NHS Foundation Trust (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Heidelberg University (1)  ·  Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1)  ·  Jean-Pierre Van geertruyden (1)  ·  King George's Medical University (1)  ·  LitePharmTech Co., Ltd. (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Tanta University (1)  ·  University Hospital, Brest (1)

Countries

United States (7)  ·  France (6)  ·  Canada (5)  ·  Poland (5)  ·  Turkey (Türkiye) (5)  ·  Argentina (3)  ·  Czechia (3)  ·  Germany (3)  ·  Italy (3)  ·  Mexico (3)  ·  Sweden (3)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Chile (2)  ·  Hungary (2)

Top investigators

Daniela Marschall-Kehrel, MD (1)  ·  Dieu Huynh, MD, PhD (1)  ·  Franz Schaefer, MD (1)  ·  Karen M Barlow, MB.ChB (1)  ·  Naveen Poonai, MD (1)  ·  Otto Mehls, MD (1)  ·  Sei Yeul Oh (1)  ·  Shally Awasthi, MD, DNB (1)  ·  Susan E Swedo, M.D. (1)

Results publications

PMID 14630977, PMID 14744931, PMID 15253732, PMID 15647341, PMID 15772249, PMID 16093916, PMID 18502028, PMID 18611959, PMID 27166296, PMID 27663941, PMID 29233751, PMID 30772471, PMID 31289192, PMID 32217739, PMID 32772826, PMID 33257343, PMID 33616185, PMID 37119829, PMID 39382077, PMID 41486550, PMID 41531337, PMID 42372625

NIH funding

2023 (2), 2009 (1), 2015 (1), R01HL123797 (1)